A Preliminary Study of Diltiazem in the Prevention of Coronary Artery Disease in Heart-Transplant Recipients
Open Access
- 21 January 1993
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 328 (3) , 164-170
- https://doi.org/10.1056/nejm199301213280303
Abstract
Accelerated coronary artery disease is a major cause of late morbidity and mortality among heart-transplant recipients. Because calcium-channel blockers can suppress diet-induced atherosclerosis in laboratory animals, we assessed the efficacy of diltiazem in preventing coronary artery disease in transplanted hearts.Keywords
This publication has 35 references indexed in Scilit:
- Effect of Nisoldipine on Diet-Induced Atherosclerosis in RabbitsAnnals of the New York Academy of Sciences, 1988
- The Antiatherosclerotic Effect of Anipamil in Cholesterol‐Fed RabbitsAnnals of the New York Academy of Sciences, 1988
- Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.Circulation, 1987
- Calcium channel blockers and atherogenesisThe American Journal of Medicine, 1987
- Effect of verapamil on accumulation of free and esterified cholesterol in the thoracic aorta of cholesterol-fed rabbitsAtherosclerosis, 1986
- Suppression of atherosclerosis in cholesterol-fed rabbits by diltiazem injection.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986
- Antiatherosclerotic effects of nicardipine and nifedipine in cholesterol-fed rabbits.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1985
- Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbitThe American Journal of Cardiology, 1984
- Verapamil suppresses atherosclerosis in cholesterol-fed rabbitsJournal of the American College of Cardiology, 1983
- Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine.Journal of Clinical Investigation, 1981